Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy SeqLL IncCommon stock stock | $3.6

Learn how to easily invest in SeqLL IncCommon stock stock.

SeqLL Inc. Common stock
- $0.14 ( - 3.89%)

SeqLL Inc. Common stock is a diagnostics & research business based in the US. SeqLL IncCommon stock shares (SQL) are listed on the NASDAQ and all prices are listed in US Dollars. SeqLL IncCommon stock employs 8 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in SeqLL IncCommon stock

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SQL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

SeqLL IncCommon stock stock price (NASDAQ: SQL)

Use our graph to track the performance of SQL stocks over time.

SeqLL IncCommon stock shares at a glance

Information last updated 2021-10-19.
Latest market close$3.60
52-week range$3.30 - $5.80
50-day moving average $3.91
200-day moving average $3.92
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.41

Buy SeqLL IncCommon stock shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy SeqLL IncCommon stock stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

SeqLL IncCommon stock price performance over time

Historical closes compared with the close of $3.6 from 2021-10-18

1 week (2021-10-13) 1.12%
1 month (2021-09-20) -5.01%
3 months (2021-07-16) N/A
6 months (2021-04-16) N/A
1 year (2020-10-16) N/A
2 years (2019-10-16) N/A
3 years (2018-10-16) N/A
5 years (2016-10-16) N/A

SeqLL IncCommon stock financials

Revenue TTM $327,271
Gross profit TTM $158,692
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation $40.5 million

TTM: trailing 12 months

Shorting SeqLL IncCommon stock shares

There are currently 89,746 SeqLL IncCommon stock shares held short by investors – that's known as SeqLL IncCommon stock's "short interest". This figure is 48.7% down from 175,027 last month.

There are a few different ways that this level of interest in shorting SeqLL IncCommon stock shares can be evaluated.

SeqLL IncCommon stock's "short interest ratio" (SIR)

SeqLL IncCommon stock's "short interest ratio" (SIR) is the quantity of SeqLL IncCommon stock shares currently shorted divided by the average quantity of SeqLL IncCommon stock shares traded daily (recently around 1.1 million). SeqLL IncCommon stock's SIR currently stands at 0.08. In other words for every 100,000 SeqLL IncCommon stock shares traded daily on the market, roughly 80 shares are currently held short.

To gain some more context, you can compare SeqLL IncCommon stock's short interest ratio against those of similar companies.

However SeqLL IncCommon stock's short interest can also be evaluated against the total number of SeqLL IncCommon stock shares, or, against the total number of tradable SeqLL IncCommon stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case SeqLL IncCommon stock's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 SeqLL IncCommon stock shares in existence, roughly 10 shares are currently held short) or 0.0504% of the tradable shares (for every 100,000 tradable SeqLL IncCommon stock shares, roughly 50 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against SeqLL IncCommon stock.

Find out more about how you can short SeqLL IncCommon stock stock.

SeqLL IncCommon stock share dividends

We're not expecting SeqLL IncCommon stock to pay a dividend over the next 12 months.

SeqLL IncCommon stock overview

SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. It designs, develops, and manufactures genetic analysis technologies; and offers true single molecule sequencing (tSMS) platform that assists researchers to develop research, diagnostics, and therapeutics applications. The company also provides RNA sequencing services and instruments, which include Direct RNA Sequencing, a genetic testing and mapping service that captures polyadenylated RNA directly without conversion to cDNA; tSMS formalin fixed paraffin embedded (FFPE) service to analyze damaged or fragmented nucleic acids from formalin fixed paraffin embedded samples and other sources; micro RNA sequencing; and custom sequencing, and mapping and testing services, as well as gene expression studies, FFPE RNA Sequencing, biomarker discovery, fusion detection, rare mutation detection, transcriptome profiling, and cap analysis gene expression services. In addition, it offers DNA sequencing services and instruments, such as shotgun DNA sequencing, direct capture sequencing, cell free DNA sequencing, FFPE DNA sequencing, ancient DNA sequencing, and targeted sequencing, as well as microbiome studies, biomarker discovery, and tumor profiling services. Further, the company provides bioinformatics services comprising data processing, biomarkers research, pathway analysis, and gene expression analysis services, as well as undertakes various custom projects. It has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc.

Frequently asked questions

What percentage of SeqLL IncCommon stock is owned by insiders?
Currently 37.346% of SeqLL IncCommon stock shares are held by insiders.
How many people work for SeqLL IncCommon stock?
Latest data suggests 8 work at SeqLL IncCommon stock.
When does the fiscal year end for SeqLL IncCommon stock?
SeqLL IncCommon stock's fiscal year ends in December.

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site